Indaptus Therapeutics is trading 5.18% higher at $2.64 on October 12, 2026; no fresh company-specific announcement has been identified to explain the move. - Search results surfaced earlier filings and previously disclosed company updates. - Major indices are near flat in a mixed broader market, and available evidence does not establish a market-wide or biotech-sector catalyst. The specific driver remains unclear.